Sign in to view content

Percentage of Patients Maintained on Quarterly Anti-VEGF Dosing for the Treatment of Neovascular Age-Related Macular Degeneration

David A. Eichenbaum, MD, FASRS

Video
Published 2018

Related

Primary Results for Protocol AB
Andrew N. Antoszyk, MD FASRS
Updates from the Field
2020
VISTA-DME Study Insights in Ellipsoid Zone Dynamics and Retinal Fluid Index
Ronald W Milam, MD
On Demand Cases, Courses, and Papers
2019
Predictors of As-Needed Ranibizumab Injection Frequency in Patients With Macular Edema Following Retinal Vein Occlusion
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2021

Category: AMD-Neovascular

Anti-VEGF

See more